Results 121 to 130 of about 3,487 (207)

Psychiatric comorbidities cluster early after onset in MOGAD: a cross-sectional comparative study with MS and NMOSD. [PDF]

J Neurol Neurosurg Psychiatry
Niederschweiberer M, Bakir C, Vorasoot N, Cacciaguerra L, Tillema JM, Vilaseca A, Thakolwiboon S, Aboseif A, Syc-Mazurek SB, Rees WA, Basso MR, Lopez-Chiriboga AS, Wingerchuk DM, Tobin WO, Croarkin PE, Sagen J, Pittock SJ, Chen JJ, Flanagan EP.   +18 more
europepmc   +1 more source

The influence of MOGAD on diagnosis of multiple sclerosis using MRI [PDF]

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is an immune-mediated demyelinating disease that is challenging to differentiate from multiple sclerosis (MS), as the clinical phenotypes overlap, and people with MOGAD can ...
Ciccarelli, Olga, Leite, M Isabel, Yousry, Tarek, DeLuca, Gabriele C, Waters, Patrick, Rocca, Mara Assunta, Filippi, Massimo, Enzinger, Christian, Chard, Declan, Paul, Friedemann, Palace, Jacqueline, Messina, Silvia, Barkhof, Frederik, MAGNIMS Study Group, Cortese, Rosa, Banwell, Brenda, Hacohen, Yael, Gasperini, Claudio, Geraldes, Ruth, Mariano, Romina, Kappos, Ludwig, Sastre-Garriga, Jaume, Arrambide, Georgina, Lassmann, Hans, Rovira, Àlex   +24 more
core  

MOGAD may not only mimic immune or infectious encephalitis, but can also be triggered by viral infections

European Journal of Case Reports in Internal Medicine
Josef Finsterer
doaj   +1 more source

Harvard MOGAD Symposium

Neurological Therapeutics, 2023
openaire   +1 more source

Diagnostic Value of the Kappa Free Light Chain Index to Distinguish MOGAD, NMOSD, and MS

International audienceBackground and objectives: The differential diagnosis between aquaporin-4-immunoglobulin G-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD ...
Marignier, Romain, Boucraut, José, Cohen, Mikael, Gavoille, Antoine, Squalli, Sanae, Maillart, Elisabeth, Ayrignac, Xavier, Laplaud, David Axel, Tournier, Apolline, Seitz-Polski, Barbara, Pique, Julie, Drouet, Thomas, Deschamps, Romain, Zephir, Helene, Boutiere, Clemence, Sterlin, Delphine, Audoin, Bertrand, Maréchal, Denis, Giannesini, Claire, Ciron, Jonathan, Ahle, Guido, Levraut, Michael, Collongues, Nicolas, Mélé, Nicolas, Vukusic, Sandra, Micoud, Eléonore, Klapczynski, Frederic, Thouvenot, Eric, Jentzer, Alexandre, Branger, Pierre, Bost, Chloe, Demortiere, Sarah   +31 more
core   +1 more source

De-Escalating and Discontinuing Immunotherapies in Patients With NMOSD and MOGAD. [PDF]

Neurology
Hacohen Y, Androdias G, Arrambide G, Bruijstens AL, Ciccarelli O, Cobo-Calvo A, Flanagan EP, Kim HJ, Iacobaeus E, Lünemann JD, Stankoff B, Tintore M, Marignier R.   +12 more
europepmc   +1 more source

Editorial: MOGAD, current knowledge and future trends

Frontiers in Neurology, 2023
Sasitorn Siritho, Sasitorn Siritho, Lekha Pandit, Lekha Pandit, Marcelo Matiello   +4 more
openaire   +3 more sources

Treatment patterns, access, and multidimensional burden of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in China: A nationwide cross-sectional study. [PDF]

Ther Adv Neurol Disord
Yu Y, Fan Y, Bao H, Ding X, Quan C, Ma C.   +5 more
europepmc   +1 more source

Myelin Oligodendrocyte Glycoprotein Antibodies in Breast Milk in a Lactating Woman With Severe Enterovirus-Associated MOGAD. [PDF]

Neurol Neuroimmunol Neuroinflamm
Kammermeier S, Heck S, Zimmermann H, Engels D, Reindl M, Kümpfel T.   +5 more
europepmc   +1 more source

Beyond Positivity: Understanding and Interpreting MOG-IgG Testing in MOGAD. [PDF]

J Clin Neurol
Chung J, Kim SH, Brilot F, Kim HJ.
europepmc   +1 more source